Healthy VolunteersPsilocybin

Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness

In healthy volunteers given psilocybin, ultra-high field fMRI revealed a recurrent hyperconnected, low‑BOLD‑amplitude brain state reflecting increased cortical arousal and overall functional connectivity. Transition probabilities into this hyperconnected pattern were linked primarily to feelings of oceanic boundlessness (and secondarily to visionary restructuralization), providing a first direct neurophenomenological association between dynamic brain states and psychedelic experience.

Authors

  • Demertzi, A.
  • Fort, L. D.
  • Mallaroni, P.

Published

Biological Psychiatry
individual Study

Abstract

Abstract To provide insights into neurophenomenological richness after psilocybin intake, we investigated the link between dynamical brain patterns and the ensuing phenomenological pattern after psilocybin intake. Healthy participants received either psilocybin (n=22) or placebo (n=27) while in ultra-high field 7T MRI scanning. Changes in the phenomenological patterns were quantified using the 5-Dimensional Altered States of Consciousness (5D-ASC) Rating Scale, revealing alterations across all dimensions under psilocybin. Changes in the neurobiological patterns displayed that psilocybin induced widespread increases in averaged functional connectivity. Time-varying connectivity analysis unveiled a recurrent hyperconnected pattern characterized by low BOLD signal amplitude, suggesting heightened cortical arousal. In terms of neurophenomenology, canonical correlation analysis primarily linked the transition probabilities of the hyperconnected pattern with feelings of oceanic boundlessness (OBN), and secondly with visionary restructuralization. We suggest that the brain’s tendency to enter a hyperconnected-hyperarousal pattern under psilocybin represents the potential to entertain variant mental associations. For the first time, these findings link brain dynamics with phenomenological alterations, providing new insights into the neurophenomenology and neurophysiology of the psychedelic state.

Unlocked with Blossom Pro

Research Summary of 'Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness'

Introduction

Classical serotonergic hallucinogens such as psilocybin produce a characteristic altered state of consciousness that combines marked subjective changes (for example ego dissolution, altered perception, hyper-associative cognition and changes in time and selfhood) with measurable shifts in brain activity and connectivity. Previous neuroimaging work has reported both averaged effects — including increased global connectivity and reduced modularity, and region-specific alterations (for example in the posterior cingulate cortex and default mode network) — and dynamic effects, with the brain visiting transient, less-stable connectivity patterns more frequently under psychedelics. However, the relationship between these time-varying neural patterns and the rich, multi-dimensional phenomenology of the psychedelic state has generally been treated separately and remains incompletely characterised. Mortaheb and colleagues set out to bridge that gap by adopting a neurophenomenological approach: they administered a single moderate dose of psilocybin or placebo to healthy adults and used ultra-high-field 7T resting-state fMRI acquired at the peak subjective effect together with the 5‑Dimensional Altered States of Consciousness (5D-ASC) questionnaire to link dynamic whole-brain functional connectivity patterns to detailed self-reported experiential dimensions. The analysis combined phase-based, time-resolved connectivity, clustering into recurrent connectivity patterns, Markov modelling of state transitions, and canonical correlation analysis to relate transition dynamics to phenomenological measures.

Results

Forty-nine healthy volunteers with prior but not recent psychedelic experience were randomised to receive either psilocybin (0.17 mg/kg; n=22, 12 male, mean age 23±2.9 years) or a placebo bittering agent (n=27, 15 male, mean age 23.1±3.8 years). Six minutes of eyes‑open resting-state fMRI were acquired on a 7T scanner during the peak subjective effect (102 minutes after dosing). Retrospective phenomenology was assessed with the 5D-ASC at 360 minutes post-dose. Phenomenology: Scores on the 5D-ASC and its 11 subscales violated normality and were compared with non-parametric tests. The psilocybin group showed significantly greater effects than placebo across all dimensions and subscales (Mann–Whitney U tests, Bonferroni-corrected), with large effect sizes; reported changes included increased oceanic boundlessness (OBN), visionary restructuralization (VRS), dread of ego dissolution and other altered-state features. Averaged connectivity and BOLD amplitude: Using the Schaefer 100-region parcellation and Pearson correlations between regional time series, whole-brain average functional connectivity was higher after psilocybin (independent t-test: t=3.087, p=0.004). A cortex-wide elevation in pairwise connectivity values was observed after multiple-comparison correction. Regional BOLD signal amplitude, quantified as the Euclidean norm of each ROI's time series, decreased in anterior and posterior cortical regions in the psilocybin group (FDR-corrected independent t-tests). The largest amplitude reductions were centred on the posterior cingulate cortex and parietal regions of the executive control network; somatomotor, limbic and temporal DMN regions did not show significant changes. Time-varying connectivity and state structure: Instantaneous phase-based coherence was computed at each time point and concatenated across subjects, then summarised by k-means clustering (500 repetitions, 200 iterations) into four recurrent connectivity centroids. The four patterns were described as: Pattern 1 — a mix of correlations and anti-correlations; Pattern 2 — anti-correlation of the DMN with other networks; Pattern 3 — global, cortex-wide positive connectivity (a hyperconnected state); and Pattern 4 — generally low inter‑areal connectivity. Pattern 3 occurred significantly more often in the psilocybin group than in placebo (independent t-test: t=3.731, p=0.001; Bonferroni-corrected α=0.0125). State transitions: Treating the four centroids as states in a Markov model, the investigators estimated transition probabilities for each subject. Compared with placebo, the psilocybin group showed higher transition probabilities towards Pattern 3 from Pattern 1 (Wilcoxon rank-sum: z=2.744, p=0.006), from Pattern 3 itself (z=2.291, p=0.022), and from Pattern 4 (z=2.000, p=0.045). Conversely, the probability of remaining in Pattern 2 (Pattern 2→Pattern 2) was lower in the psilocybin group (z=-2.452, p=0.014). Neurophenomenological associations: Canonical correlation analysis (CCA) was used to relate the set of between‑state transition probabilities to the 11-ASC phenomenological factors. The first canonical correlation was very strong (r=0.97, p<0.001). In the neural set, the transition probability from Pattern 1 to Pattern 3 showed the highest loading on the first canonical variate (r=0.86, p<0.001), with smaller but significant loadings for Pattern 2→1 (r=0.47, p=0.015) and Pattern 4→3 (r=0.40, p=0.048). In the phenomenological set, OBN-related subscales had the largest correlations with the first canonical variate: experience of unity (r=0.80, p<0.001), blissful state (r=0.74, p<0.001), insightfulness (r=0.68, p<0.001), spiritual experience (r=0.62, p<0.001) and disembodiment (r=0.35, p=0.036). VRS subscales also loaded on the variate (elementary imagery r=0.67, audio–video synesthesia r=0.61, complex imagery r=0.50, changed meaning of percept r=0.50; p-values ≤0.001 for many). A validation CCA using the 5D-ASC dimensions produced a similar pattern: the neural 1→3 transition showed highest correlation with the neural canonical variate (r=0.89, p<0.001) and OBN dominated the phenomenological variate (r=0.93, p<0.001). These results indicate that the brain's increased tendency to enter the global hyperconnected pattern under psilocybin is primarily associated with reports of oceanic boundlessness and, to a lesser extent, visionary restructuralization.

Discussion

Mortaheb and colleagues interpret their findings as evidence that a moderate dose of psilocybin increases the brain's propensity to enter a globally hyperconnected, low‑BOLD‑amplitude state and that this dynamical tendency maps onto specific subjective changes, especially oceanic boundlessness (OBN) and visionary restructuralization (VRS). Behaviourally, the study replicated prior dose‑dependent phenomenological effects of psilocybin across multiple 5D-ASC dimensions. Neurally, both averaged and dynamic analyses pointed to greater global integration: whole‑brain connectivity increased, and time-resolved analysis revealed a recurrent, functionally non‑specific hyperconnected pattern that occurred more often and was more readily entered under psilocybin. The authors situate these results within a dynamical systems framing commonly invoked in psychedelic research: psychedelics flatten the brain's attractor landscape so that functionally specific connectivity states become less dominant and transitions between states are easier. In this dataset, that interpretation is supported by higher transition probabilities into the hyperconnected state and by reduced occurrence of some self‑specific patterns (for example reduced self‑transition probability in Pattern 2). The hyperconnected pattern was accompanied by lower global signal (GS) amplitude as measured from the BOLD norm; retaining the GS was an explicit analytical choice and the authors note prior evidence that lower GS amplitude is associated with higher cortical arousal. From this perspective, the authors argue that the hyperconnected–low‑GS configuration reflects heightened cortical arousal and increased capacity for diverse mental associations, which plausibly underpins experiences such as unity, bliss and insight. Linking dynamics and phenomenology, canonical correlation analysis indicated that transitions into the global hyperconnected pattern were most strongly associated with OBN subscales (unity, bliss, insight) and then with VRS subscales. The authors emphasise that OBN — a positive, ego‑dissolution‑related dimension — may be the principal phenomenological driver of psilocybin's effects, a conclusion aligned with earlier work linking OBN to clinical outcomes in psilocybin‑assisted therapy and to neurochemical and connectivity markers. They suggest the hyperconnected pattern's combination of high integration and low segregation offers a mechanistic account for experiences that require loosening of self–world boundaries. Several limitations are acknowledged. The chosen dose was moderate and did not produce total ego dissolution in all participants; it was selected to be tolerable in the 7T scanner. The absence of concurrent physiological and electrophysiological recordings limits the ability to disambiguate vascular or peripheral contributions to the GS and to relate hyperconnected states to neuronal firing or arousal more directly. Finally, the authors note the data‑driven nature of the analyses and that findings may be specific to the recruited sample, although they point to prior work showing reproducible recurrent connectivity motifs across datasets. They recommend future studies include simultaneous physiological/electrophysiological measures and explore a range of doses and populations. In closing, the study concludes that psilocybin produces coordinated alterations in brain dynamics and subjective experience, with a recurrent global hyperconnected pattern most closely linked to feelings of oceanic boundlessness and visual restructuralization.

View full paper sections

METHODS

Participants. Data were collected from 49 healthy participants with previous experience with a psychedelic drug, but not within the past 3 months of the experiment. Participants were randomized to receive a single dose of psilocybin (0.17 mg/kg, n=22; 12 male; age=23±2.9 y) or placebo (n=27; 15 male; age=23.1±3.8 y). This study was conducted according to the code of ethics on human experimentation established by the Declaration of Helsinki (1964) and amended in Fortaleza (Brazil, October 2013). This study is in accordance with the Medical Research Involving Human Subjects Act (WMO) and was approved by the Academic Hospital and the University's Medical Ethics Committee (Maastricht University, Netherlands Trial Register: NTR6505). All participants were fully informed of all procedures, possible adverse reactions, legal rights, responsibilities, expected benefits, and their right to voluntary termination without consequences.

RESULTS

Data was collected from 49 healthy participants who had previous experience with a psychedelic drug but not within the past three months 1 . Participants were allocated to two groups after being randomized to receive a single dose of psilocybin (0.17 mg/kg, n=22 (12 male, age=23±2.9 y) or placebo (bittering agent; n=27 (15 male, age=23.1±3.8 y). Six minutes of resting state with eyes open were acquired on a fMRI ultra-high field 7T scanner during the peak subjective drug effect (102 min post-treatment). The 5-Dimensional Altered States of Consciousness (5D-ASC) Rating Scalewas retrospectively evaluated at 360 min after drug administration.

CONCLUSION

We investigated the effect of the serotonergic hallucinogen psilocybin on the brain's functional connectome to link them with alternations of conscious experience to better comprehend how the resulting neural and experiential changes are interconnected. Overall, we found that psilocybin administration led to a tendency of the brain to recurrently configure in a globally hyperconnected pattern, which was linked to heightened reports of oceanic boundlessness (experience of unity, blissfulness, insightfulness, and spiritual experience), and visionary restructuralization (complex imagery, elementary imagery, audio-visual synesthesia, and changed meaning of percepts). In terms of phenomenological changes, we report significant increases in all phenomenological dimensions and factors in the psilocybin group over the placebo. This includes increased reports of derealization, depersonalization, loss of self-control phenomena, elementary and complex visual pseudo-hallucinations, audio-visual synesthesia, experiences of unity, spiritual experience, bliss, insightfulness, and disembodiment, as we previously reported 1 . These findings evidence that a moderate dose of psilocybin is enough to produce a significantly distinct phenomenological pattern when compared to a placebo. Previous research on psilocybin administration also found that dosages ranging from 45 to 315 μg/kg body weight produced measurable changes in oceanic boundlessness (OBN), visionary restructuralization (VRS), auditory alternations (AUA), vigilance reduction (VIR), and general altered states score (G-ASC) compared to placebo. Additional research found that 260 μg/kg body weight of psilocybin produced significant changes in OBN, dread of ego dissolution (DED), and VRS when compared to placebo, ketanserin, and psilocybin with a pretreatment of ketanserin conditions. Taken together, our data replicates the general, dosedependent, phenomenological pattern associated with psilocybin consumption. In terms of neural changes, we observed an overall increase in whole-brain functional connectivity in the psilocybin group, in line with previous reports. Previous work showed that serotonergic psychedelics, including psilocybin, changed the brain's functional organization into a new architecture, characterized by greater global integration, namely a higher amount of short-range and long-range functional connections. This dynamic analysis evidenced that, under psilocybin, the brain had a higher probability of transitioning to a hyperconnected pattern compared to the placebo group. Similar configurations and dynamic transitions have been reported by other studies with psychedelic drugs, as well. This hyperconnected pattern is characterized by maximal integration and minimal segregationand is interpreted as being functionally non-specific. The significantly higher occurrence rate of this hyperconnected pattern in the psychedelic state can be explained by the "flattened landscape" theory. Based on this dynamic systems approach, specific connectivity patterns, which act as attractors in typical conditions, become less dominant under psychedelics. Consequently, the brain expends less energy transitioning between these states. This supports that the occurrence rate of functionally specific patterns in our analysis results in increased transition probabilities to enter the functionally non-specific hyperconnected pattern. Moreover, we observed that this hyperconnectivity pattern is accompanied by cortex-wide decreases in the BOLD signal amplitude in the psilocybin group. We here decided to retain the global signal (GS) in the analysis pipeline, while acknowledging the significant debate around its removal as part of the denoising process. On one hand, the GS has demonstrated a neuronal counterpart., on the other, it was shown to reflect fMRI nuisance sources such as motion, scanner artifacts, respiration, cardiac rate, and vascular activity. Our choice to keep the GS is justified by our recent finding that it can act as a complementary metric to extracted connectivity patterns. Specifically, we found that when the hyperconnected pattern was accompanied by high GS amplitude during wakeful rest, it was more probable for participants to report phenomenological instances of mind blanking 60 (i.e., the subjective evaluation of having no thoughts during unconstrained mentation). The amplitude of the GS has been previously shown to act as an indirect measure of general arousal levels. For example, higher GS amplitude was related to lower levels of arousal, and lower GS amplitudes were linked to higher levels of arousal. Indeed, it was demonstrated that the GS amplitude correlated positively with the relative amplitude of the delta band of EEG oscillations and negatively with the relative amplitude of the alpha band. In the current study, we show that the hyperconnectivity pattern is accompanied by reduced GS amplitude, therefore adding to the explanation of the psychedelic state as mediated by high cortical arousal. In terms of neurophenomenology, we show that higher transition probabilities into the hyperconnected pattern are significantly associated with the factors of oceanic boundlessness (OBN) and visionary restructuralization (VRS). OBN is characterized by deeply felt positive mood, feelings of insight, and experiences of unity. Previous studies associated positively experienced ego dissolution and oceanic boundlessness with reduced levels of hippocampal glutamate 1 and higher feelings of insight with reduced levels of DMN within-network static functional connectivity. Our whole-brain dynamic analysis complements this literature by showing that the brain's tendency to be recurrently hyperconnected after psilocybin intake can also explain the experiences of unity. This is important as this factor is characterized by a disruption of the selfworld boundary 1 and the hyperconnected pattern is characterized by an atypical minimal segregation profile. Other studies showed that both integration and segregation are necessary for a coherent sense of self. Given these two main findings, we postulate that the reported feelings of unity and visual pseudo-hallucinatory experiences under psilocybin are connected to the brain's inclination to exhibit highly integrated patterns, thereby evidencing the brain's capacity to entertain diverse mental associations. This can be supported by the fact that different dimensions of creative thinking improve after psilocybin intake as a result of increased between-network functional connectivity of DMN and frontoparietal network, 28 a connectivity profile also seen in the hyperconnected pattern. Interestingly, three of the five factors of OBN (unity, bliss, insight) represented the highest canonical correlations in our analysis, while the visual restructuralization (VRS) factors followed. This was further supported by canonical correlations performed at the dimensional level, which showed OBN as having the highest association with transition probabilities to the hyperconnected pattern comparatively. This is a unique finding given that serotonergic psychedelics are sometimes referred to as hallucinogens, leaving one to assume that their primary effects are hallucinatory in nature. Indeed, such an issue can be seen historically in the etymology of these drugs as they have been referred to as psychotomimetics, psycholytics, hallucinogens, psychedelics, or entheogens at different points in time. Psilocybin-assisted therapy studies also show that the clinical outcome is driven primarily by OBN, supporting its primary role in the drug's phenomenological effect. OBN's central importance is further supported by its association with decreased 5-HT2AR binding potential in cortical regions,its ability to predict medial prefrontal cortex-posterior cingulate cortex functional connectivity changes,and its positive correlation with disconnection of somatomotor network correlates. Since OBN is defined as the positive valence associated with depersonalization and derealization through factors such as unity, that require dissolution of the selfworld boundary, it can be seen primarily as a psychometric dimension that describes phenomenological modifications of the ego. Our data, along with previous research, suggests that OBN is the primary driver of the psychedelic state's general phenomenological pattern. As a consequence, future work might provide more refined terminologies to capture this driving effect of psilocybin, such as "egotropic" over "hallucinogenic". Our study is subject to various limitations. First, at the group level, the administration of psilocybin was not high enough to induce total ego dissolution for all participants. The administered dose was selected to be sufficient to induce a psychedelic state that participants could endure in an ultra-high field scanner environment. However, our phenomenological analysis showed that this dosage was adequate. Second, the lack of concurrent physiological recordings during fMRI scanning limits proper tracking of arousal levels. In this study, we used the GS amplitude as a proxy for the level of cortical arousal. At the same time, the absence of simultaneous electrophysiological recordings limits the direct interpretation of neuronal firing during hyperconnected patterns. Simultaneous physiological and electrophysiological recordings in future studies can help to better investigate the role of cortical and general arousal with neuronal firing patterns in producing mystical experiences during the psychedelic state. Finally, the data-driven nature of the analysis can limit the results of the current study to the recruited population. However, this is less concerning in the dynamic functional connectivity analysis as in our previous studies it was shown that similar recurrent connectivity patterns can be derived in different datasets and different brain parcellations, showing their replicability and universality. In conclusion, we found that pharmacological perturbations using psilocybin generate profound alterations both at the brain and at the experiential level. We showed that administration of psilocybin leads to an increase in the brain's tendency to configure into a functionally non-specific hyperconnected organization, which phenomenologically associates with experiences of oceanic boundlessness and visual pseudo-hallucinations. The present findings illuminate the intricate interplay between brain dynamics and subjective experience under psilocybin, providing new insights into the neurophenomenology and neurophysiology of the psychedelic state.

Study Details

Your Library